Skip to main content

All Publications

Minesh Mehta, Miami Cancer InstituteFollow

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

Publication Date

7-15-2020

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

International Journal of Radiation Oncology, Biology, Physics (2020) 107(4):720-725

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS